Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy

被引：0
|
作者：
不详
机构：
来源：
TOXICOLOGIC PATHOLOGY | 2004年 / 32卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：749 / 750
页数：2
相关论文
共 50 条
  • [31] eIF4E modulators to address breast cancer resistance
    Sturla, Lisa
    Dekky, Bassil
    Zhang, Xuemei
    Bowdish, Katherine S.
    VanDeusen, Chris
    CANCER RESEARCH, 2022, 82 (12)
  • [32] eIF4E与肿瘤
    王晓琳
    蔡洪培
    中国肿瘤生物治疗杂志, 2010, 17 (04) : 473 - 477
  • [33] eIF4E与胃癌
    方海洋
    李群星
    国际肿瘤学杂志, 2009, (04) : 291 - 293
  • [34] EGPI-1, a novel eIF4E/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras/MNK/ERK/eIF4E signaling pathway
    Qi, Xueju
    Zhang, Shuna
    Chen, Zekun
    Wang, Lijun
    Zhu, Wenyong
    Yin, Chuanjin
    Fan, Junting
    Wu, Xiaochen
    Wang, Jing
    Guo, Chuanlong
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 352
  • [35] Translational control of cancer via eIF4E/4E-BPs
    Sonenberg, Nahum
    CANCER RESEARCH, 2013, 73
  • [36] eIF4E binding protein 1 expression is associated with clinical survival outcomes in colorectal cancer
    Chao, Min-Wu
    Wang, Li-Ting
    Lai, Chin-Yu
    Yang, Xiao-Ming
    Cheng, Ya-Wen
    Lee, Kuo-Hsiung
    Pan, Shiow-Lin
    Teng, Che-Ming
    ONCOTARGET, 2015, 6 (27): : 24092 - 24104
  • [37] Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer
    Sampoorna Satheesha
    Victoria J Cookson
    Louise J Coleman
    Nicola Ingram
    Brijesh Madhok
    Andrew M Hanby
    Charlotte AB Suleman
    Vicky S Sabine
    E Jane Macaskill
    John MS Bartlett
    J Michael Dixon
    Jim N McElwaine
    Thomas A Hughes
    Molecular Cancer, 10
  • [38] Characterization of the MAPK/Mnk/eIF4E signaling pathway in several breast cancer cell lines
    Garcia-Recio, E. M.
    Perez-Morgado, M. I.
    Garcia-Hernandez, M.
    Gonzalez, V. M.
    Marti, M. E.
    FEBS JOURNAL, 2012, 279 : 326 - 326
  • [39] Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
    Urtishak, Karen A.
    Wang, Li-San
    Culjkovic-Kraljacic, Biljana
    Davenport, James W.
    Porazzi, Patrizia
    Vincent, Tiffaney L.
    Teachey, David T.
    Tasian, Sarah K.
    Moore, Jonni S.
    Seif, Alix E.
    Jin, Shenghao
    Barrett, Jeffrey S.
    Robinson, Blaine W.
    Chen, I-Ming L.
    Harvey, Richard C.
    Carroll, Martin P.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Devidas, Meenakshi
    Dreyer, ZoAnn E.
    Hilden, Joanne M.
    Hunger, Stephen P.
    Willman, Cheryl L.
    Borden, Katherine L. B.
    Felix, Carolyn A.
    ONCOGENE, 2019, 38 (13) : 2241 - 2262
  • [40] Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer
    Satheesha, Sampoorna
    Cookson, Victoria J.
    Coleman, Louise J.
    Ingram, Nicola
    Madhok, Brijesh
    Hanby, Andrew M.
    Suleman, Charlotte A. B.
    Sabine, Vicky S.
    Macaskill, E. Jane
    Bartlett, John M. S.
    Dixon, J. Michael
    McElwaine, Jim N.
    Hughes, Thomas A.
    MOLECULAR CANCER, 2011, 10
12345